<DOC>
	<DOC>NCT00333918</DOC>
	<brief_summary>The primary objective of this study is to investigate the efficacy and safety of bromfenac ophthalmic solution for treatment of ocular inflammation and pain in subjects who undergo cataract extraction and intraocular lens implantation.</brief_summary>
	<brief_title>Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Scheduled for unilateral cataract surgery with no other ophthalmic surgical procedures planned during cataract surgery Agree to return for all required visits Agree to avoid disallowed medications Known hypersensitivity to bromfenac and salicylates</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Cataract Extraction</keyword>
	<keyword>Anti-Inflammatory Agents, Non-Steroidal</keyword>
</DOC>